COST-EFFECTIVENESS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN FILIPINO ADULTS AGED $50 YEARS

被引:0
|
作者
Santiaguel, J. [1 ]
Nua, W. [2 ]
Atwood, M. [3 ]
Huang, L. [4 ]
Hariharan, D. [3 ]
Guerrero, J. [2 ]
Zotomayor, R. C. [5 ]
Averin, A.
机构
[1] IUP PGH Med Ctr, Manila, Philippines
[2] Pfizer Inc, Makati, Philippines
[3] Policy Anal Inc PAI, Boston, MA USA
[4] Pfizer Inc, Collegeville, PA USA
[5] UERMMMC Inc SLMC, Quezon City, Philippines
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE592
引用
收藏
页码:S167 / S167
页数:1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN INDIAN ADULTS AGED ≥60 YEARS
    Kulkarni, N.
    Averin, A.
    Taur, S.
    Huang, L.
    Hariharan, D.
    Atwood, M.
    Gupta, N.
    VALUE IN HEALTH, 2023, 26 (12) : S136 - S136
  • [2] COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS IN PORTUGAL
    Alarcao, J.
    Fiorentino, F.
    Gouveia, M.
    Jesus, G.
    Costa, J.
    Borges, M.
    VALUE IN HEALTH, 2016, 19 (07) : A414 - A414
  • [3] Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Among Adults in the Philippines
    Santiaguel, Joel
    Averin, Ahuva
    Nua, Winniefer
    Atwood, Mark
    Huang, Liping
    Hariharan, Dhwani
    Guerrero, Josephine
    Zotomayor, Ricardo
    David-Wang, Aileen
    VALUE IN HEALTH REGIONAL ISSUES, 2025, 47
  • [4] Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland
    Blank, Patricia R.
    Szucs, Thomas D.
    VACCINE, 2012, 30 (28) : 4267 - 4275
  • [5] Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States
    Stoecker, Charles
    Kim, Lindsay
    Gierke, Ryan
    Pilishvili, Tamara
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 (08) : 901 - 908
  • [6] Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States
    Charles Stoecker
    Lindsay Kim
    Ryan Gierke
    Tamara Pilishvili
    Journal of General Internal Medicine, 2016, 31 : 901 - 908
  • [7] Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
    Jaime E Ordóñez
    John J Orozco
    BMC Infectious Diseases, 14
  • [8] Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
    Ordonez, Jaime E.
    Orozco, John J.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [9] THE COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CHINESE CITIES
    Furnback, W.
    Wang, B. C. M.
    Zhu, S.
    Dong, P.
    VALUE IN HEALTH, 2020, 23 : S170 - S170
  • [10] Cost-effectiveness of the 13-valent Pneumococcal Conjugate Vaccine in Children in Portugal
    Gouveia, Miguel
    Fiorentino, Francesca
    Jesus, Goncalo
    Costa, Joao
    Borges, Margarida
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (08) : 782 - 787